Alglucerase

Description

Alglucerase was a biopharmaceutical drug for the treatment of Gaucher’s disease. It was a modified form of human β-glucocerebrosidase enzyme, where the non-reducing ends of the oligosaccharide chains have been terminated with mannose residues.

Medicine classification

ATC Code
Title
Class
Alglucerase
A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes

Unique Ingredient Identifier (UNII)

27T56C7KK0 - ALGLUCERASE

CAS Registry Number

143003-46-7 - alglucerase

SNOMED-CT

329497002 - Alglucerase (substance)